Cost of pancreatic cancer care reduced by the introduction of new medicines

Written by Georgia Cousins

Results from a health economic outcomes study reveal that the introduction of more effective prescription drug therapies is having such a great therapeutic benefit, it is actually driving a decrease in the total cost of healthcare for pancreatic cancer patients. Pancreatic cancer has one of the lowest survival rates among the different cancer types; there is still a great unmet need for treatment options for pancreatic cancer patients. Research into new and effective therapeutics is ongoing, but at what cost? In this study, researchers carrying out a health economic outcomes study at the Virginia Mason Medical Center (WA, USA) analyzed...

To view the full article, please register now for access

It's completely free